Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hepatitis C Virus
100%
Injection Drug Users
100%
Hepatitis C Virus Treatment
66%
Sustained Viral Response
41%
HIV-infected Patients
41%
Directly Observed Therapy
33%
Models of Care
33%
Drug Resistance
25%
Once-weekly
16%
Genotype 1
16%
Group Treatment
16%
Therapy Models
16%
Group Therapy
16%
Fear of Side-effects
8%
Psychiatric Care
8%
Resistant Virus
8%
Acute Hepatitis C
8%
Methadone Clinic
8%
Daily Dose
8%
Online Treatment
8%
Weekly Injection
8%
Treatment Group
8%
Adherence Level
8%
Improved Survival
8%
Direct-acting Antivirals
8%
Clinical Trials
8%
Oral Medication
8%
Primary Care
8%
Cost-effectiveness Analysis
8%
Treatment Model
8%
Randomized Controlled Trial
8%
Methadone
8%
Virological Failure
8%
Substance Abuse Treatment
8%
HIV Co-infection
8%
Hepatitis C Virus Genotypes
8%
Pegylated Interferon
8%
Treatment Outcome
8%
Response Rate
8%
Social Support
8%
HIV Care
8%
Multidisciplinary Model
8%
New Regimens
8%
Drug Development
8%
Opiate Agonist Treatment
8%
Specific Aims
8%
Nursing and Health Professions
Drug Use
100%
Hepatitis C
100%
Injection
100%
Human Immunodeficiency Virus
25%
Sustained Virologic Response
25%
Group Therapy
20%
Directly Observed Therapy
20%
Model of Care
20%
Drug Resistance
15%
Adherence
15%
Methadone
10%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis C Virus
100%
HIV
25%
Drug Resistance
15%
Methadone
10%